Key result
Obesity prevalence is steadily growing globally, with sample surveys in Russia indicating that up to 30% of the working population are overweight and 25% have obesity.
The high and growing prevalence of obesity globally and in Russia highlights the need for adequate pharmacotherapy.
Rising obesity prevalence signals need for effective pharmacotherapy; leaves open optimal strategies for working populations.
The high prevalence of obesity is a serious medical and social problem conditioned by urbanization, reduced physical activity and availability of high-calorie food. All over the world, the prevalence of obesity has been steadily growing over the last few decades: body mass index increased by 0,4--0,5 over a decade globally [1-3]. Sample surveys conducted in Russia showed that at present, up to 30% of the working population of the country are overweight and 25% have obesity. That is why WHO defined obesity as the noninfectious epidemic of the XX-XXI centuries. [4--8].
No takes yet. Share an insight, caveat, or question.
Maksimov et al. (2016) conducted a review in Obesity. Pharmacotherapy was evaluated. Obesity prevalence is steadily growing globally, with sample surveys in Russia indicating that up to 30% of the working population are overweight and 25% have obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: